Insights

Gathering insights about BillionToOne…

Similar companies to BillionToOne

BillionToOne Tech Stack

BillionToOne uses 8 technology products and services including Illumina, SQL, Google Workspace, and more. Explore BillionToOne's tech stack below.

Illumina
Data Management
SQL
Database
Google Workspace
Email
Vue.js
Javascript Frameworks
Microsoft Azure
Platform As A Service
Greenhouse
Recruitment Marketing
PCI DSS
Risk And Compliance
Adobe Fonts
Web Fonts

Media & News

BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for BillionToOne (BLLN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
May 06, 2026 | www.zacks.com
BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the first quarter ended March 31, 2026 and raised guidance for full year 2026.
May 06, 2026 | www.globenewswire.com
BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics
A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne's Fetal Cell Capture™ Technology MENLO PARK, Calif., May 1, 2026 /PRNewswire/ -- For more than two decades, the ultimate quest for scientists and clinicians studying prenatal genetics was the capture of an intact fetal cell non-invasively so that its fetal DNA could be directly analyzed.
May 01, 2026 | www.prnewswire.com
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
Renowned physician executive and clinician-scientist joins BillionToOne to advance oncology medical strategy MENLO PARK, Calif., April 2, 2026 /PRNewswire/ -- BillionToOne , Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company focused on making highly accurate testing accessible to all, today announced the appointment of Allen Chen, MD, MBA, FASTRO, FACHE, as Vice President of Medical Affairs and Clinical Development, Oncology.
Apr 02, 2026 | www.prnewswire.com
Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the ten analysts that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and six have given a buy recommendation to the
Mar 11, 2026 | www.defenseworld.net
BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript
BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript
Mar 06, 2026 | seekingalpha.com
BillionToOne: Delivering And Lagging At The Same Time
BillionToOne delivers strong growth in molecular diagnostics, achieving profitability and raising 2026 revenue guidance to $430–$445 million. BillionToOne's Q4 sales rose 113% to $96.1 million, driven by prenatal testing; oncology growth was slower sequentially but remains a long-term diversification lever. I view current guidance as conservative, with recent product launches and coverage deals not fully reflected in the outlook, supporting further upside potential.
Mar 06, 2026 | seekingalpha.com

BillionToOne's Email Address Formats

BillionToOne uses at least 1 format(s):

BillionToOne Email Formats	Example	Percentage
FLast@billiontoone.com	JDoe@billiontoone.com	79%
Last@billiontoone.com	Doe@billiontoone.com	12%
First@billiontoone.com	John@billiontoone.com	8%
First.Last@billiontoone.com	John.Doe@billiontoone.com	1%

Frequently Asked Questions

Where is BillionToOne's headquarters located?

BillionToOne's main headquarters is located at 1035 O'brien Drive Menlo Park, California 94025 United States. The company has employees across 2 continents, including North AmericaAsia.

What is BillionToOne's stock symbol?

BillionToOne is a publicly traded company; the company's stock symbol is BLLN.

What is BillionToOne's official website and social media links?

BillionToOne's official website is billiontoone.com and has social profiles on LinkedIn Crunchbase.

What is BillionToOne's SIC code NAICS code?

BillionToOne's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BillionToOne have currently?

As of April 2026, BillionToOne has approximately 730 employees across 2 continents, including North AmericaAsia. Key team members include Chief Medical Officer, Oncology: G. P.Chief Financial Officer: N. S.Vp Of Market Access: C. M.. Explore BillionToOne's employee directory with LeadIQ.

What industry does BillionToOne belong to?

BillionToOne operates in the Biotechnology Research industry.

What technology does BillionToOne use?

BillionToOne's tech stack includes IlluminaSQLGoogle WorkspaceVue.jsMicrosoft AzureGreenhousePCI DSSAdobe Fonts.

What is BillionToOne's email format?

BillionToOne's email format typically follows the pattern of FLast@billiontoone.com. Find more BillionToOne email formats with LeadIQ.

How much funding has BillionToOne raised to date?

As of April 2026, BillionToOne has raised $103M in funding. The last funding round occurred on Jun 14, 2021 for $55M.

When was BillionToOne founded?

BillionToOne was founded in 2016.

BillionToOne

Q: What is BillionToOne's official website and social media links?

BillionToOne's official website is billiontoone.com. BillionToOne has social profiles on LinkedIn.

Q: How many employees does BillionToOne have currently?

BillionToOne has approximately 730 employees.

Q: What technology does BillionToOne use?

BillionToOne's tech stack includes RSS, Tableau, Adobe Fonts, Facebook, Google Tag Manager.

Q: What is BillionToOne's NAICS code?

BillionToOne's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States501-1000 Employees

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.

Company Overview

Headquarters: 1035 O'brien Drive Menlo Park, California 94025 United States
Website: billiontoone.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: BLLN
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 501-1000

Media & News

Funding & Financials

$103M
BillionToOne has raised a total of $103M of funding over 3 rounds. Their latest funding round was raised on Jun 14, 2021 in the amount of $55Mas a Series B.
$100M$250M
BillionToOne's revenue is estimated to be in the range of $100M$250M

Funding & Financials

$103M
BillionToOne has raised a total of $103M of funding over 3 rounds. Their latest funding round was raised on Jun 14, 2021 in the amount of $55Mas a Series B.
$100M$250M
BillionToOne's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to BillionToOne

bioMérieux

QIAGEN

Roche

Natera

Guardant Health

Myriad Genetics

Thermo Fisher Scientific

Agilent Technologies

Exact Sciences

Illumina

PerkinElmer

Cepheid

Labcorp

BillionToOne Tech Stack

Media & News

BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Rating of “Moderate Buy” by Analysts

BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript

BillionToOne: Delivering And Lagging At The Same Time

BillionToOne's Email Address Formats

Frequently Asked Questions

Where is BillionToOne's headquarters located?

What is BillionToOne's stock symbol?

What is BillionToOne's official website and social media links?

What is BillionToOne's SIC code NAICS code?

How many employees does BillionToOne have currently?

What industry does BillionToOne belong to?

What technology does BillionToOne use?

What is BillionToOne's email format?

How much funding has BillionToOne raised to date?

When was BillionToOne founded?

BillionToOne

Company Overview

Media & News

BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?